相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N-cadherin Restrains PTH Activation of Lrp6/β-catenin Signaling and Osteoanabolic Action
Leila Revollo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Marc N Wein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Update on romosozumab: a humanized monoclonal antibody to sclerostin
Aline G. Costa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Class I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation
Stefan Baertschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Review of Osteocyte Function and the Emerging Importance of Sclerostin
Jocelyn T. Compton et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
HDAC4 integrates PTH and sympathetic signaling in osteoblasts
Arnaud Obri et al.
JOURNAL OF CELL BIOLOGY (2014)
Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats
H. B. Jia et al.
OSTEOPOROSIS INTERNATIONAL (2014)
LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling
Changjun Li et al.
BONE RESEARCH (2014)
Effects of PTH on osteocyte function
Teresita Bellido et al.
BONE (2013)
Disruption of LRP6 in Osteoblasts Blunts the Bone Anabolic Activity of PTH
Changjun Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
TGF-β regulates sclerostin expression via the ECR5 enhancer
Gabriela G. Loots et al.
BONE (2012)
Mef2c deletion in osteocytes results in increased bone mass
Ina Kramer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling
Bing Yu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts
Sang Wan Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
Lingling Xian et al.
NATURE MEDICINE (2012)
Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin
Nicolas Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeted deletion of Sost distal enhancer increases bone formation and bone mass
Nicole M. Collette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antagonists of LRP6 regulate PTH-induced cAMP generation
Chenhui Shi et al.
SKELETAL BIOLOGY AND MEDICINE I (2011)
Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo
Kyu Sang Joeng et al.
DEVELOPMENTAL BIOLOGY (2011)
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis
E. Michael Lewiecki
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling
Yumie Rhee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Amazing Osteocyte
Lynda F. Bonewald
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses
William F. Powell et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Damian C. Genetos et al.
PLOS ONE (2011)
LRP6 Mediates cAMP Generation by G Protein-Coupled Receptors Through Regulating the Membrane Targeting of Gαs
Mei Wan et al.
SCIENCE SIGNALING (2011)
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
J. H. Gooi et al.
BONE (2010)
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
Jun Guo et al.
CELL METABOLISM (2010)
Inhibition of Sca-1-Positive Skeletal Stem Cell Recruitment by Alendronate Blunts the Anabolic Effects of Parathyroid Hormone on Bone Remodeling
Xiangwei Wu et al.
CELL STEM CELL (2010)
Phospholipase C Signaling via the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Essential for Normal Bone Responses to PTH
Jun Guo et al.
ENDOCRINOLOGY (2010)
PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats
Beverley Fermor et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Matthew T. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Does osteocytic SOST suppression mediate PTH bone anabolism?
Ina Kramer et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies
Fernando Rivadeneira et al.
NATURE GENETICS (2009)
TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation
Yi Tang et al.
NATURE MEDICINE (2009)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Mei Wan et al.
GENES & DEVELOPMENT (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo
Ramakrishnaiah Siddappa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MEF2: a central regulator of diverse developmental programs
Matthew J. Potthoff et al.
DEVELOPMENT (2007)
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
Olivier Leupin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone
G. Silvestrini et al.
JOURNAL OF MOLECULAR HISTOLOGY (2007)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
PTH stimulates bone formation in mice deficient in Lrp5
Urszula T. Iwaniec et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment
Kimihiko Sawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
G-protein signaling: back to the future
CR McCudden et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands
TM Murray et al.
ENDOCRINE REVIEWS (2005)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Parathyroid hormone: a double-edged sword for bone metabolism
L Qin et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization
M Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
